Hu et al. have found that KCNQ1OT1 up-regulates the expression of ABCC1, thereby increasing the chemotherapy resistance of oxaliplatin to hepatocellular carcinoma (Sun et al. 2018b). This evidence concerns the gene KCNQ1OT1 and hepatocellular carcinoma.